Intrinsic Value of S&P & Nasdaq Contact Us

Pfizer Inc. PFE NYSE

NYSE • Healthcare • Drug Manufacturers - General • US • USD

SharesGrow Score
65/100
3/7 Pass
SharesGrow Intrinsic Value
$17.48
-35.6%
Analyst Price Target
$27.50
+1.4%

Pfizer Inc. (PFE) is a publicly traded company in the Healthcare sector, operating within the Drug Manufacturers - General industry. The company is headquartered in New York City, NY, United States. The current CEO is Albert Bourla.

PFE has IPO date of 1972-06-01, 81,000 full-time employees, listed on the NYSE, a market capitalization of $154.33B.

About Pfizer Inc.

Pfizer Inc. is a global biopharmaceutical company that discovers, develops, manufactures, and distributes medicines and vaccines across multiple therapeutic areas worldwide. The company's portfolio includes cardiovascular and metabolic treatments, oncology and immunotherapy drugs, vaccines for infectious diseases including COVID-19, and biosimilars for chronic inflammatory conditions, with leading brands such as Eliquis, Ibrance, Comirnaty, and Paxlovid. Pfizer serves diverse healthcare customers including wholesalers, retailers, hospitals, pharmacies, and government agencies, while also operating a contract manufacturing business. Founded in 1849 and headquartered in New York, Pfizer collaborates with numerous pharmaceutical and biotechnology partners to expand its innovation pipeline.

📍 66 Hudson Boulevard East, New York City, NY 10001-2192 📞 212 733 2323
Company Details
SectorHealthcare
IndustryDrug Manufacturers - General
CountryUnited States
ExchangeNYSE
CurrencyUSD
IPO Date1972-06-01
CEOAlbert Bourla
Employees81,000
Trading Info
Current Price$27.13
Market Cap$154.33B
52-Week Range20.92-28.745
Beta0.39
ETFNo
ADRNo
CUSIP717081103
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message